Background: Pulmonary hypertension (PH) patients show, during exercise, an excessive increase in ventilation (VE) compared to carbon dioxide output (VCO2), determining a high VE/VCO2 slope. There are several possible causes, including an elevated dead space ventilation (VD), VE/perfusion (Q) mismatch and/or an enhanced peripheral or central chemoreceptor activity. We evaluated the causes of exercise hyperventilation in PH patients. Methods: Eighteen group I and IV PH patients underwent cardiopulmonary exercise test with blood gas analysis at every minute. VE, alveolar ventilation (VA) and VD vs. VCO2 relationship were calculated. Resting chemoreceptor sensitivity was analyzed through hypoxia/hypercapnia tests. Results: PeakVO2 and VE/VCO2 slopes were 1.06 ± 0.24 l/min and 39.1 ± 9.0, respectively. Throughout the exercise, 30% of VE was due to VD. VE/VCO2 slope significantly correlated with VD/VCO2 slope (r = 0.82, p < 0.001) but not with VA/VCO2 slope (r = 0.3, p = ns). Peak exercise end-tidal CO2 (PetCO2) correlated with VD/VCO2 slope (r = − 0.79, p < 0.001) and VE/VCO2 slope (r = − 0.91, p < 0.001). Dead space(DS)/Tidal volume and P(arterial-et)CO2 were elevated without arterial hypoxemia suggesting a high VE/Q mismatch. Chemoreceptor peripheral response to hypoxia and central CO2 response were both enhanced being peripheral responses to hypoxia and hypercapnia 0.416 ± 0.402 (normal ref values = 0.285 ± 0.221) l/min/O2Sat and 0.076 ± 0.047 (0.066 ± 0.430) l/min/mmHg, respectively; central hypercapnic chemosensitivity was 4.475 ± 3.99 (2.352 ± 0.936) l/min/mmHg. Conclusions: Increased DS, VE/Q mismatch and chemorecptor response are among the main mechanisms involved in exercise hyperventilation in PH. ClinicalTrial.gov NCT02892981.

Physiological insights of exercise hyperventilation in arterial and chronic thromboembolic pulmonary hypertension / S. Farina, N. Bruno, C. Agalbato, M. Contini, R. Cassandro, D.E. Bisceglia, S. Harari, P. Agostoni. - In: INTERNATIONAL JOURNAL OF CARDIOLOGY. - ISSN 0167-5273. - 259(2018 May 15), pp. 178-182. [10.1016/j.ijcard.2017.11.023]

Physiological insights of exercise hyperventilation in arterial and chronic thromboembolic pulmonary hypertension

S. Farina
Primo
;
C. Agalbato;S. Harari;P. Agostoni
Ultimo
2018

Abstract

Background: Pulmonary hypertension (PH) patients show, during exercise, an excessive increase in ventilation (VE) compared to carbon dioxide output (VCO2), determining a high VE/VCO2 slope. There are several possible causes, including an elevated dead space ventilation (VD), VE/perfusion (Q) mismatch and/or an enhanced peripheral or central chemoreceptor activity. We evaluated the causes of exercise hyperventilation in PH patients. Methods: Eighteen group I and IV PH patients underwent cardiopulmonary exercise test with blood gas analysis at every minute. VE, alveolar ventilation (VA) and VD vs. VCO2 relationship were calculated. Resting chemoreceptor sensitivity was analyzed through hypoxia/hypercapnia tests. Results: PeakVO2 and VE/VCO2 slopes were 1.06 ± 0.24 l/min and 39.1 ± 9.0, respectively. Throughout the exercise, 30% of VE was due to VD. VE/VCO2 slope significantly correlated with VD/VCO2 slope (r = 0.82, p < 0.001) but not with VA/VCO2 slope (r = 0.3, p = ns). Peak exercise end-tidal CO2 (PetCO2) correlated with VD/VCO2 slope (r = − 0.79, p < 0.001) and VE/VCO2 slope (r = − 0.91, p < 0.001). Dead space(DS)/Tidal volume and P(arterial-et)CO2 were elevated without arterial hypoxemia suggesting a high VE/Q mismatch. Chemoreceptor peripheral response to hypoxia and central CO2 response were both enhanced being peripheral responses to hypoxia and hypercapnia 0.416 ± 0.402 (normal ref values = 0.285 ± 0.221) l/min/O2Sat and 0.076 ± 0.047 (0.066 ± 0.430) l/min/mmHg, respectively; central hypercapnic chemosensitivity was 4.475 ± 3.99 (2.352 ± 0.936) l/min/mmHg. Conclusions: Increased DS, VE/Q mismatch and chemorecptor response are among the main mechanisms involved in exercise hyperventilation in PH. ClinicalTrial.gov NCT02892981.
chemoreceptors; dead space ventilation; pulmonary hypertension; pulmonary ventilation
Settore MED/11 - Malattie dell'Apparato Cardiovascolare
15-mag-2018
Article (author)
File in questo prodotto:
File Dimensione Formato  
PG AGOSTONI 10.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 358.61 kB
Formato Adobe PDF
358.61 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/580972
Citazioni
  • ???jsp.display-item.citation.pmc??? 19
  • Scopus 40
  • ???jsp.display-item.citation.isi??? 38
social impact